Shares of Novo Nordisk and Eli Lilly took a hit after Swiss pharma giant Roche posted positive results for its experimental weight loss pill. Roche said early Wednesday morning that its weight ...

The headline trial results will be closely monitored by pharmaceutical industry experts. Shares in Novo Nordisk, which ...

Ozempic, Wegovy or Mounjaro: the battle of the weight-loss injections - As weight-loss injections emerge as key players in ...

Shares of Viking Therapeutics (NASDAQ:VKTX) jumped 22% Monday morning after the biotech firm reported promising results for ...

A turbulent series of events surrounding the supply of Eli Lilly’s blockbuster weight loss treatment has raised concerns around how the Food and Drug Administration maintains its list of drug ...

Oct 21 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, the main ingredient in its ...

Eli Lilly has suffered a major setback after the US regulator rejected its rheumatoid arthritis pill, baricitinib, sending the company’s share price plummeting. Lilly received a letter from the ...

VK2735, which is being developed in both as an injectable and in pill form, is most closely related to Lilly's Zepbound (tirzepatide), given that both are dual GLP-1/GIP agonist. The oral form of ...

Here are the key points about Viking Therapeutics' oral obesity drug VK2735: Early-Stage Trial Results: All doses of VK2735 ...

Lilly's Mounjaro to cost 2,200 Danish crowns ... are cleared for weight loss in combination with a reduced-calorie diet and increased physical activity, and come with added health benefits ...